CAR-T cell therapy, originally developed for cancer, is showing ever more promise as a treatment for autoimmune diseases.
The new data bolster Allogene’s efforts to develop a new, easily administered cell therapy that could delay or prevent cancer recurrence.
Mary Bird Perkins Cancer Center in Baton Rouge, Louisiana is offering a CAR-T cell-based immunotherapy, which genetically ...
CAR-T cell therapy, originally developed for cancer, is showing ever more promise as a treatment for autoimmune diseases.
Cancers that were once considered incurable now have new treatment options. Among these innovations are CAR-T (chimeric ...
Since 2017, a personalized immunotherapy called Chimeric Antigen Receptor, or CAR-T cell treatment, has worked wonders to ...
A New Hope for Patients with Advanced Gastric and Pancreatic Cancers SHANGHAI, April 9, 2026 /PRNewswire/ -- A groundbreaking new CAR-T cell therapy for advanced gastrointestinal cancers is expected ...
IFLScience on MSN
CAR-T therapy is revolutionizing cancer treatment. Next on the list: autoimmune disease
A woman who had been sick for many years with three autoimmune conditions has experienced a remarkable recovery after being ...
Initial results from a high-stakes trial indicate the biotech may have finally found a niche in lymphoma care for a ...
New Scientist on MSN
CAR T-cell therapy takes woman from bedridden to 'perfectly fine'
A woman with three different autoimmune conditions had all of them treated simultaneously by genetically modifying her immune ...
For the first time, scientists have used a modern cell therapy called CAR-T to treat a patient with three different ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results